Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Breast Cancer

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 264 articles:
HTML format
Text format



Single Articles


    January 2018
  1. OLIVEIRA MMF, Gurgel MSC, Amorim BJ, Ramos CD, et al
    Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial.
    PLoS One. 2018;13:e0189176.
    PubMed     Text format     Abstract available


  2. THAKUR SS, Li H, Chan AMY, Tudor R, et al
    The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
    PLoS One. 2018;13:e0188983.
    PubMed     Text format     Abstract available


  3. SANNACHI L, Gangeh M, Tadayyon H, Sadeghi-Naini A, et al
    Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features.
    PLoS One. 2018;13:e0189634.
    PubMed     Text format     Abstract available


  4. HADJIALIREZAEI S, Picco G, Beatson R, Burchell J, et al
    Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    PLoS One. 2018;13:e0190814.
    PubMed     Text format     Abstract available


  5. KROIGARD AB, Larsen MJ, Laenkholm AV, Knoop AS, et al
    Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression.
    PLoS One. 2018;13:e0189887.
    PubMed     Text format     Abstract available


  6. BROMBERG SE, Moraes PRAF, Ades F
    Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    PLoS One. 2018;13:e0191056.
    PubMed     Text format     Abstract available


  7. HILDENBRAND G, Metzler P, Pilarczyk G, Bobu V, et al
    Dose enhancement effects of gold nanoparticles specifically targeting RNA in breast cancer cells.
    PLoS One. 2018;13:e0190183.
    PubMed     Text format     Abstract available


  8. LI T, Zhao J, Yang J, Ma X, et al
    Correction: A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    PLoS One. 2018;13:e0191579.
    PubMed     Text format     Abstract available


  9. KHALIS M, Charbotel B, Chajes V, Rinaldi S, et al
    Menstrual and reproductive factors and risk of breast cancer: A case-control study in the Fez region, Morocco.
    PLoS One. 2018;13:e0191333.
    PubMed     Text format     Abstract available


  10. TSAI HP, Huang SF, Li CF, Chien HT, et al
    Differential microRNA expression in breast cancer with different onset age.
    PLoS One. 2018;13:e0191195.
    PubMed     Text format     Abstract available


  11. SYED BM, Morgan D, Setty T, Green AR, et al
    Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2018;13:e0191979.
    PubMed     Text format     Abstract available


  12. KIM J, Choi SH, Ham SJ, Cho YC, et al
    Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model.
    PLoS One. 2018;13:e0187063.
    PubMed     Text format     Abstract available


  13. BOUGARET L, Delort L, Billard H, Le Huede C, et al
    Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen.
    PLoS One. 2018;13:e0191571.
    PubMed     Text format     Abstract available


  14. KHAN MM, Mendes A, Chalup SK
    Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction.
    PLoS One. 2018;13:e0192192.
    PubMed     Text format     Abstract available


  15. RUSSO-ABRAHAO T, Lacerda-Abreu MA, Gomes T, Cosentino-Gomes D, et al
    Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231.
    PLoS One. 2018;13:e0191270.
    PubMed     Text format     Abstract available


  16. BELCHER DA, Ju JA, Baek JH, Yalamanoglu A, et al
    The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study.
    PLoS One. 2018;13:e0191275.
    PubMed     Text format     Abstract available


  17. BRADFORD JR, Cox A, Bernard P, Camp NJ, et al
    Correction: Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    PLoS One. 2018;13:e0192589.
    PubMed     Text format     Abstract available


  18. ZHANG J, Yang J, Zhang X, Xu J, et al
    MicroRNA-10b expression in breast cancer and its clinical association.
    PLoS One. 2018;13:e0192509.
    PubMed     Text format     Abstract available


  19. JOFFE M, Ayeni O, Norris SA, McCormack VA, et al
    Barriers to early presentation of breast cancer among women in Soweto, South Africa.
    PLoS One. 2018;13:e0192071.
    PubMed     Text format     Abstract available


  20. PATEL N, Garikapati KR, Makani VKK, Nair AD, et al
    Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
    PLoS One. 2018;13:e0190245.
    PubMed     Text format     Abstract available


  21. VACHER S, Castagnet P, Chemlali W, Lallemand F, et al
    High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
    PLoS One. 2018;13:e0190619.
    PubMed     Text format     Abstract available


  22. THAKRAN S, Chatterjee S, Singhal M, Gupta RK, et al
    Automatic outer and inner breast tissue segmentation using multi-parametric MRI images of breast tumor patients.
    PLoS One. 2018;13:e0190348.
    PubMed     Text format     Abstract available


  23. CALA MP, Aldana J, Medina J, Sanchez J, et al
    Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.
    PLoS One. 2018;13:e0190958.
    PubMed     Text format     Abstract available


  24. ROHAN T, Ye K, Wang Y, Glass AG, et al
    MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer.
    PLoS One. 2018;13:e0191814.
    PubMed     Text format     Abstract available


  25. YUAN H, Chen V, Boisvert M, Isaacs C, et al
    PLAC1 as a serum biomarker for breast cancer.
    PLoS One. 2018;13:e0192106.
    PubMed     Text format     Abstract available


  26. ZIAI J, Gilbert HN, Foreman O, Eastham-Anderson J, et al
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    PLoS One. 2018;13:e0190158.
    PubMed     Text format     Abstract available


  27. HO PJ, Hartman M, Young-Afat DA, Gernaat SAM, et al
    Determinants of satisfaction with cosmetic outcome in breast cancer survivors: A cross-sectional study.
    PLoS One. 2018;13:e0193099.
    PubMed     Text format     Abstract available


  28. JENSEN-JOHANSEN MB, O'Toole MS, Christensen S, Valdimarsdottir H, et al
    Expressive writing intervention and self-reported physical health out-comes - Results from a nationwide randomized controlled trial with breast cancer patients.
    PLoS One. 2018;13:e0192729.
    PubMed     Text format     Abstract available


  29. DE GROEF A, Van Kampen M, Moortgat P, Anthonissen M, et al
    An evaluation tool for Myofascial Adhesions in Patients after Breast Cancer (MAP-BC evaluation tool): Concurrent, face and content validity.
    PLoS One. 2018;13:e0193915.
    PubMed     Text format     Abstract available


  30. BOSE C, Awasthi S, Sharma R, Benes H, et al
    Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.
    PLoS One. 2018;13:e0193918.
    PubMed     Text format     Abstract available


  31. HUSSAIN A, Yong C, Tkaczuk KHR, Qian Y, et al
    Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer.
    PLoS One. 2018;13:e0193661.
    PubMed     Text format     Abstract available


  32. ALMOTWAA S, Elrobh M, AbdulKarim H, Alanazi M, et al
    Genetic polymorphism and expression of HSF1 gene is significantly associated with breast cancer in Saudi females.
    PLoS One. 2018;13:e0193095.
    PubMed     Text format     Abstract available


  33. VREEMANN S, Gubern-Merida A, Borelli C, Bult P, et al
    The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
    PLoS One. 2018;13:e0191399.
    PubMed     Text format     Abstract available


  34. LAGUNIN AA, Dubovskaja VI, Rudik AV, Pogodin PV, et al
    CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds.
    PLoS One. 2018;13:e0191838.
    PubMed     Text format     Abstract available


  35. ZHAO X, Wei J, Li X, Yang H, et al
    Increasing negative lymph node count predicts favorable OS and DSS in breast cancer with different lymph node-positive subgroups.
    PLoS One. 2018;13:e0193784.
    PubMed     Text format     Abstract available


  36. HELLEC C, Delos M, Carpentier M, Denys A, et al
    The heparan sulfate 3-O-sulfotransferases (HS3ST) 2, 3B and 4 enhance proliferation and survival in breast cancer MDA-MB-231 cells.
    PLoS One. 2018;13:e0194676.
    PubMed     Text format     Abstract available


  37. MAHMUD A, Aljunid SM
    Availability and accessibility of subsidized mammogram screening program in peninsular Malaysia: A preliminary study using travel impedance approach.
    PLoS One. 2018;13:e0191764.
    PubMed     Text format     Abstract available


  38. DVORAK KM, Pettee KM, Rubinic-Minotti K, Su R, et al
    Carcinoma associated fibroblasts (CAFs) promote breast cancer motility by suppressing mammalian Diaphanous-related formin-2 (mDia2).
    PLoS One. 2018;13:e0195278.
    PubMed     Text format     Abstract available


  39. ARYAL B, Rao VA
    Specific protein carbonylation in human breast cancer tissue compared to adjacent healthy epithelial tissue.
    PLoS One. 2018;13:e0194164.
    PubMed     Text format     Abstract available


  40. TAMEZ-PENA JG, Rodriguez-Rojas JA, Gomez-Rueda H, Celaya-Padilla JM, et al
    Radiogenomics analysis identifies correlations of digital mammography with clinical molecular signatures in breast cancer.
    PLoS One. 2018;13:e0193871.
    PubMed     Text format     Abstract available


  41. KHAJAH MA, Mathew PM, Luqmani YA
    Na+/K+ ATPase activity promotes invasion of endocrine resistant breast cancer cells.
    PLoS One. 2018;13:e0193779.
    PubMed     Text format     Abstract available


  42. NGUYEN CP, Adang EMM
    Cost-effectiveness of breast cancer screening using mammography in Vietnamese women.
    PLoS One. 2018;13:e0194996.
    PubMed     Text format     Abstract available


  43. BROMBERG SE, Moraes PRAF, Ades F
    Correction: Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    PLoS One. 2018;13:e0195130.
    PubMed     Text format     Abstract available


  44. LUENGO-GIL G, Gonzalez-Billalabeitia E, Perez-Henarejos SA, Navarro Manzano E, et al
    Angiogenic role of miR-20a in breast cancer.
    PLoS One. 2018;13:e0194638.
    PubMed     Text format     Abstract available


  45. BAMBHROLIYA A, Van Wyhe RD, Kumar S, Debeb BG, et al
    Gene set analysis of post-lactational mammary gland involution gene signatures in inflammatory and triple-negative breast cancer.
    PLoS One. 2018;13:e0192689.
    PubMed     Text format     Abstract available


  46. HAN Q, Chen R, Wang F, Chen S, et al
    Pre-exposure to 50 Hz-electromagnetic fields enhanced the antiproliferative efficacy of 5-fluorouracil in breast cancer MCF-7 cells.
    PLoS One. 2018;13:e0192888.
    PubMed     Text format     Abstract available


  47. LUCHSINGER C, Aguilar M, Burgos PV, Ehrenfeld P, et al
    Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.
    PLoS One. 2018;13:e0195401.
    PubMed     Text format     Abstract available


  48. HORIBATA S, Rice EJ, Zheng H, Mukai C, et al
    A bi-stable feedback loop between GDNF, EGR1, and ERalpha contribute to endocrine resistant breast cancer.
    PLoS One. 2018;13:e0194522.
    PubMed     Text format     Abstract available


  49. HORIBATA S, Rice EJ, Mukai C, Marks BA, et al
    ER-positive breast cancer cells are poised for RET-mediated endocrine resistance.
    PLoS One. 2018;13:e0194023.
    PubMed     Text format     Abstract available


  50. NAM SY, Ko ES, Lim Y, Han BK, et al
    Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.
    PLoS One. 2018;13:e0195756.
    PubMed     Text format     Abstract available


  51. CHU LW, John EM, Yang B, Kurian AW, et al
    Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies.
    PLoS One. 2018;13:e0195666.
    PubMed     Text format     Abstract available


  52. SANDLIN RD, Wong KHK, Tessier SN, Swei A, et al
    Ultra-fast vitrification of patient-derived circulating tumor cell lines.
    PLoS One. 2018;13:e0192734.
    PubMed     Text format     Abstract available


  53. SEO IS, Lee HG, Koo B, Koh CS, et al
    Cross detection for odor of metabolic waste between breast and colorectal cancer using canine olfaction.
    PLoS One. 2018;13:e0192629.
    PubMed     Text format     Abstract available


  54. KORONOWICZ AA, Drozdowska M, Wielgos B, Piasna-Slupecka E, et al
    The effect of "NutramilTM Complex," food for special medical purpose, on breast and prostate carcinoma cells.
    PLoS One. 2018;13:e0192860.
    PubMed     Text format     Abstract available


  55. DEWALD JH, Cavdarli S, Steenackers A, Delannoy CP, et al
    TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
    PLoS One. 2018;13:e0196369.
    PubMed     Text format     Abstract available


  56. PARISE C, Caggiano V
    The influence of marital status and race/ethnicity on risk of mortality for triple negative breast cancer.
    PLoS One. 2018;13:e0196134.
    PubMed     Text format     Abstract available


  57. TISSIER R, Houwing-Duistermaat J, Rodriguez-Girondo M
    Improving stability of prediction models based on correlated omics data by using network approaches.
    PLoS One. 2018;13:e0192853.
    PubMed     Text format     Abstract available


  58. FRICKE IB, De Souza R, Costa Ayub L, Francia G, et al
    Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
    PLoS One. 2018;13:e0196892.
    PubMed     Text format     Abstract available


  59. VERONESE P, Hachul DT, Scanavacca MI, Hajjar LA, et al
    Effects of anthracycline, cyclophosphamide and taxane chemotherapy on QTc measurements in patients with breast cancer.
    PLoS One. 2018;13:e0196763.
    PubMed     Text format     Abstract available


  60. KOVAC B, Makela TP, Vallenius T
    Increased alpha-actinin-1 destabilizes E-cadherin-based adhesions and associates with poor prognosis in basal-like breast cancer.
    PLoS One. 2018;13:e0196986.
    PubMed     Text format     Abstract available


  61. SENARAS C, Niazi MKK, Sahiner B, Pennell MP, et al
    Optimized generation of high-resolution phantom images using cGAN: Application to quantification of Ki67 breast cancer images.
    PLoS One. 2018;13:e0196846.
    PubMed     Text format     Abstract available


  62. FATIMA I, El-Ayachi I, Taotao L, Angeles Lillo M, et al
    Correction: The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    PLoS One. 2018;13:e0197796.
    PubMed     Text format     Abstract available


  63. ECKHARDT BL, Gagliardi M, Iles L, Evans K, et al
    Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.
    PLoS One. 2018;13:e0195932.
    PubMed     Text format     Abstract available


  64. LIM ST, Park CH, Kim SY, Nam SJ, et al
    The effect of adjuvant chemotherapy on survival in Korean patients with node negative T1c, triple negative breast cancer.
    PLoS One. 2018;13:e0197523.
    PubMed     Text format     Abstract available


  65. ZENG Z, Jiang X, Li X, Wells A, et al
    Conjugated equine estrogen and medroxyprogesterone acetate are associated with decreased risk of breast cancer relative to bioidentical hormone therapy and controls.
    PLoS One. 2018;13:e0197064.
    PubMed     Text format     Abstract available


  66. KHARMAN-BIZ A, Gao H, Ghiasvand R, Haldosen LA, et al
    Expression of the three components of linear ubiquitin assembly complex in breast cancer.
    PLoS One. 2018;13:e0197183.
    PubMed     Text format     Abstract available


  67. RACCAGNI I, Belloli S, Valtorta S, Stefano A, et al
    [18F]FDG and [18F]FLT PET for the evaluation of response to neo-adjuvant chemotherapy in a model of triple negative breast cancer.
    PLoS One. 2018;13:e0197754.
    PubMed     Text format     Abstract available



  68. Retraction: Calcium Channel Blockers and Risk of Breast Cancer: A Meta-Analysis of 17 Observational Studies.
    PLoS One. 2018;13:e0198220.
    PubMed     Text format    


  69. STRUIK GM, Vrijland WW, Birnie E, Klem TMAL, et al
    A randomized controlled trial on the effect of a silver carboxymethylcellulose dressing on surgical site infections after breast cancer surgery.
    PLoS One. 2018;13:e0195715.
    PubMed     Text format     Abstract available


  70. HUBBELING HG, Rosenberg SM, Gonzalez-Robledo MC, Cohn JG, et al
    Psychosocial needs of young breast cancer survivors in Mexico City, Mexico.
    PLoS One. 2018;13:e0197931.
    PubMed     Text format     Abstract available


  71. PAVANELLO S, Varesco L, Gismondi V, Bruzzi P, et al
    Leucocytes telomere length and breast cancer risk/ susceptibility: A case-control study.
    PLoS One. 2018;13:e0197522.
    PubMed     Text format     Abstract available


  72. RAINEY L, van der Waal D, Donnelly LS, Evans DG, et al
    Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
    PLoS One. 2018;13:e0197772.
    PubMed     Text format     Abstract available


  73. HARALDSDOTTIR A, Torfadottir JE, Valdimarsdottir UA, Adami HO, et al
    Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    PLoS One. 2018;13:e0198017.
    PubMed     Text format     Abstract available


  74. GHOSH A, Sarkar S, Banerjee S, Behbod F, et al
    MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis.
    PLoS One. 2018;13:e0198143.
    PubMed     Text format     Abstract available


  75. VEYS I, Pop CF, Barbieux R, Moreau M, et al
    ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.
    PLoS One. 2018;13:e0197857.
    PubMed     Text format     Abstract available


  76. ALHAMAMI M, Cheng W, Lyu Y, Allen C, et al
    Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
    PLoS One. 2018;13:e0196998.
    PubMed     Text format     Abstract available


  77. CRUZ-ROA A, Gilmore H, Basavanhally A, Feldman M, et al
    High-throughput adaptive sampling for whole-slide histopathology image analysis (HASHI) via convolutional neural networks: Application to invasive breast cancer detection.
    PLoS One. 2018;13:e0196828.
    PubMed     Text format     Abstract available


  78. GU S, Ngamcherdtrakul W, Reda M, Hu Z, et al
    Lack of acquired resistance in HER2-positive breast cancer cells after long-term HER2 siRNA nanoparticle treatment.
    PLoS One. 2018;13:e0198141.
    PubMed     Text format     Abstract available


  79. FORMA E, Jozwiak P, Ciesielski P, Zaczek A, et al
    Impact of OGT deregulation on EZH2 target genes FOXA1 and FOXC1 expression in breast cancer cells.
    PLoS One. 2018;13:e0198351.
    PubMed     Text format     Abstract available


  80. HAN X, Zhao J, Ruddy KJ, Lin CC, et al
    The impact of dependent coverage expansion under the Affordable Care Act on time to breast cancer treatment among young women.
    PLoS One. 2018;13:e0198771.
    PubMed     Text format     Abstract available


  81. ASTVATSATURYAN K, Yue Y, Walts AE, Bose S, et al
    Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features.
    PLoS One. 2018;13:e0197827.
    PubMed     Text format     Abstract available


  82. ALI S, Malik MZ, Singh SS, Chirom K, et al
    Exploring novel key regulators in breast cancer network.
    PLoS One. 2018;13:e0198525.
    PubMed     Text format     Abstract available


  83. EASTLACK SC, Dong S, Mo YY, Alahari SK, et al
    Expression of long noncoding RNA MALAT1 correlates with increased levels of Nischarin and inhibits oncogenic cell functions in breast cancer.
    PLoS One. 2018;13:e0198945.
    PubMed     Text format     Abstract available


  84. MCDONNELL SL, Baggerly CA, French CB, Baggerly LL, et al
    Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations >/=60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort.
    PLoS One. 2018;13:e0199265.
    PubMed     Text format     Abstract available


  85. HENRY TR, Marshall SA, Avis NE, Levine BJ, et al
    Concordance networks and application to clustering cancer symptomology.
    PLoS One. 2018;13:e0191981.
    PubMed     Text format     Abstract available


  86. LESICKA M, Jablonska E, Wieczorek E, Seroczynska B, et al
    Altered circadian genes expression in breast cancer tissue according to the clinical characteristics.
    PLoS One. 2018;13:e0199622.
    PubMed     Text format     Abstract available


  87. BOYNE DJ, King WD, Brenner DR, McIntyre JB, et al
    Aerobic exercise and DNA methylation in postmenopausal women: An ancillary analysis of the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial.
    PLoS One. 2018;13:e0198641.
    PubMed     Text format     Abstract available


  88. LOBBA ARM, Carreira ACO, Cerqueira OLD, Fujita A, et al
    High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors.
    PLoS One. 2018;13:e0199254.
    PubMed     Text format     Abstract available


  89. MARTIN CL, Tate DF, Valle CG
    Nonadherence to daily self-weighing and activity tracking is associated with weight fluctuations among African American breast cancer survivors.
    PLoS One. 2018;13:e0199751.
    PubMed     Text format     Abstract available


  90. VOUTOURI C, Stylianopoulos T
    Accumulation of mechanical forces in tumors is related to hyaluronan content and tissue stiffness.
    PLoS One. 2018;13:e0193801.
    PubMed     Text format     Abstract available


  91. HORIE Y, Makihara H, Horikawa K, Takeshige F, et al
    Reduced skin lipid content in obese Japanese women mediated by decreased expression of rate-limiting lipogenic enzymes.
    PLoS One. 2018;13:e0193830.
    PubMed     Text format     Abstract available


  92. GODLEWSKA M, Krasuska W, Czarnocka B
    Biochemical properties of thyroid peroxidase (TPO) expressed in human breast and mammary-derived cell lines.
    PLoS One. 2018;13:e0193624.
    PubMed     Text format     Abstract available


  93. WITTKOWSKI KM, Dadurian C, Seybold MP, Kim HS, et al
    Complex polymorphisms in endocytosis genes suggest alpha-cyclodextrin as a treatment for breast cancer.
    PLoS One. 2018;13:e0199012.
    PubMed     Text format     Abstract available


  94. CHEN Z, Ai L, Mboge MY, Tu C, et al
    Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
    PLoS One. 2018;13:e0199476.
    PubMed     Text format     Abstract available


  95. TAKABAYASHI M, Majeed H, Kajdacsy-Balla A, Popescu G, et al
    Disorder strength measured by quantitative phase imaging as intrinsic cancer marker in fixed tissue biopsies.
    PLoS One. 2018;13:e0194320.
    PubMed     Text format     Abstract available


  96. CHOI SW, Ryu SY, Han MA, Park J, et al
    Higher breast cancer prevalence associated with higher socioeconomic status in the South Korean population; Has it resulted from overdiagnosis?
    PLoS One. 2018;13:e0200484.
    PubMed     Text format     Abstract available


  97. KIM YY, Oh SJ, Chun YS, Lee WK, et al
    Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer.
    PLoS One. 2018;13:e0200100.
    PubMed     Text format     Abstract available


  98. TYURYUMINA EY, Neznanov AA
    Consolidated mathematical growth model of the primary tumor and secondary distant metastases of breast cancer (CoMPaS).
    PLoS One. 2018;13:e0200148.
    PubMed     Text format     Abstract available


  99. SUN X, Stewart DA, Sandhu R, Kirk EL, et al
    Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue.
    PLoS One. 2018;13:e0193792.
    PubMed     Text format     Abstract available


  100. BINDER K, Krauss S, Bruckmaier G, Marienhagen J, et al
    Visualizing the Bayesian 2-test case: The effect of tree diagrams on medical decision making.
    PLoS One. 2018;13:e0195029.
    PubMed     Text format     Abstract available


  101. PANNUTI A, Filipovic A, Hicks C, Lefkowitz E, et al
    Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.
    PLoS One. 2018;13:e0194790.
    PubMed     Text format     Abstract available


  102. SETYOWIBOWO H, Purba FD, Hunfeld JAM, Iskandarsyah A, et al
    Quality of life and health status of Indonesian women with breast cancer symptoms before the definitive diagnosis: A comparison with Indonesian women in general.
    PLoS One. 2018;13:e0200966.
    PubMed     Text format     Abstract available


  103. DEPARDON E, Kanoun S, Humbert O, Bertaut A, et al
    FDG PET/CT for prognostic stratification of patients with metastatic breast cancer treated with first line systemic therapy: Comparison of EORTC criteria and PERCIST.
    PLoS One. 2018;13:e0199529.
    PubMed     Text format     Abstract available


  104. MITCHELL R, Buckingham L, Cobleigh M, Rotmensch J, et al
    Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?
    PLoS One. 2018;13:e0195497.
    PubMed     Text format     Abstract available


  105. PETURSSON HI, Kovacs A, Mattsson J, Olofsson Bagge R, et al
    Evaluation of intraoperative touch imprint cytology on axillary sentinel lymph nodes in invasive breast carcinomas, a retrospective study of 1227 patients comparing sensitivity in the different tumor subtypes.
    PLoS One. 2018;13:e0195560.
    PubMed     Text format     Abstract available


  106. AL-AJMI K, Lophatananon A, Ollier W, Muir KR, et al
    Risk of breast cancer in the UK biobank female cohort and its relationship to anthropometric and reproductive factors.
    PLoS One. 2018;13:e0201097.
    PubMed     Text format     Abstract available


  107. CHO U, Park HS, Im SY, Yoo CY, et al
    Prognostic value of systemic inflammatory markers and development of a nomogram in breast cancer.
    PLoS One. 2018;13:e0200936.
    PubMed     Text format     Abstract available


  108. GUO J, Liu C, Wang W, Liu Y, et al
    Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer.
    PLoS One. 2018;13:e0200716.
    PubMed     Text format     Abstract available


  109. DANIELS B, Girosi F, Tervonen H, Kiely BE, et al
    Adherence to prescribing restrictions for HER2-positive metastatic breast cancer in Australia: A national population-based observational study (2001-2016).
    PLoS One. 2018;13:e0198152.
    PubMed     Text format     Abstract available


  110. HILTON J, Stober C, Mazzarello S, Vandermeer L, et al
    Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial).
    PLoS One. 2018;13:e0199297.
    PubMed     Text format     Abstract available


  111. KASSARDJIAN A, Shintaku PI, Moatamed NA
    Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas.
    PLoS One. 2018;13:e0195958.
    PubMed     Text format     Abstract available


  112. GOUSSIA A, Simou N, Zagouri F, Manousou K, et al
    Associations of angiogenesis-related proteins with specific prognostic factors, breast cancer subtypes and survival outcome in early-stage breast cancer patients. A Hellenic Cooperative Oncology Group (HeCOG) trial.
    PLoS One. 2018;13:e0200302.
    PubMed     Text format     Abstract available


  113. MESSEHA SS, Zarmouh NO, Mendonca P, Alwagdani H, et al
    The inhibitory effects of plumbagin on the NF-B pathway and CCL2 release in racially different triple-negative breast cancer cells.
    PLoS One. 2018;13:e0201116.
    PubMed     Text format     Abstract available


  114. SAEUI CT, Nairn AV, Galizzi M, Douville C, et al
    Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.
    PLoS One. 2018;13:e0195812.
    PubMed     Text format     Abstract available


  115. OGATA H, Mitsuzuka Y, Honma N, Yoshida M, et al
    Sonographic visualization of nipple blood flow can help differentiate Paget disease from benign eczematous nipple lesions.
    PLoS One. 2018;13:e0197156.
    PubMed     Text format     Abstract available


  116. KUMAR V, Webb JM, Gregory A, Denis M, et al
    Automated and real-time segmentation of suspicious breast masses using convolutional neural network.
    PLoS One. 2018;13:e0195816.
    PubMed     Text format     Abstract available


  117. TSAI CW, Chang WS, Shen TC, Su CH, et al
    Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk.
    PLoS One. 2018;13:e0202112.
    PubMed     Text format     Abstract available



  118. Retraction: Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.
    PLoS One. 2018;13:e0202299.
    PubMed     Text format    


  119. LI X, Rouchka EC, Brock GN, Yan J, et al
    A combined approach with gene-wise normalization improves the analysis of RNA-seq data in human breast cancer subtypes.
    PLoS One. 2018;13:e0201813.
    PubMed     Text format     Abstract available


  120. UDDIN MM, Zou Y, Sharma T, Gatla HR, et al
    Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy.
    PLoS One. 2018;13:e0201858.
    PubMed     Text format     Abstract available


  121. BANNOUD N, Carvelli FL, Troncoso M, Sartor T, et al
    Cation-dependent mannose-6-phosphate receptor expression and distribution are influenced by estradiol in MCF-7 breast cancer cells.
    PLoS One. 2018;13:e0201844.
    PubMed     Text format     Abstract available


  122. KUROZUMI S, Matsumoto H, Inoue K, Tozuka K, et al
    Impact of combining the progesterone receptor and preoperative endocrine prognostic index (PEPI) as a prognostic factor after neoadjuvant endocrine therapy using aromatase inhibitors in postmenopausal ER positive and HER2 negative breast cancer.
    PLoS One. 2018;13:e0201846.
    PubMed     Text format     Abstract available


  123. COTE D, Eustace A, Toomey S, Cremona M, et al
    Germline single nucleotide polymorphisms in ERBB3 and BARD1 genes result in a worse relapse free survival response for HER2-positive breast cancer patients treated with adjuvant based docetaxel, carboplatin and trastuzumab (TCH).
    PLoS One. 2018;13:e0200996.
    PubMed     Text format     Abstract available


  124. FIGUEIREDO FWDS, Almeida TCDC, Schoueri JHM, Luisi C, et al
    Association between primary care coverage and breast cancer mortality in Brazil.
    PLoS One. 2018;13:e0200125.
    PubMed     Text format     Abstract available



  125. Retraction: Chaperonin CCT-Mediated AIB1 Folding Promotes the Growth of ERalpha-Positive Breast Cancer Cells on Hard Substrates.
    PLoS One. 2018;13:e0202617.
    PubMed     Text format    


  126. GOMEZ-ACEBO I, Dierssen-Sotos T, Palazuelos C, Fernandez-Navarro P, et al
    Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study.
    PLoS One. 2018;13:e0201750.
    PubMed     Text format     Abstract available


  127. KHALID S, Hanif R, Jabeen I, Mansoor Q, et al
    Pharmacophore modeling for identification of anti-IGF-1R drugs and in-vitro validation of fulvestrant as a potential inhibitor.
    PLoS One. 2018;13:e0196312.
    PubMed     Text format     Abstract available


  128. IPPOLITO E, Fiore M, Di Donato A, Silipigni S, et al
    Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system.
    PLoS One. 2018;13:e0195506.
    PubMed     Text format     Abstract available


  129. GOMES RS, Moreira FTC, Fernandes R, Sales MGF, et al
    Sensing CA 15-3 in point-of-care by electropolymerizing O-phenylenediamine (oPDA) on Au-screen printed electrodes.
    PLoS One. 2018;13:e0196656.
    PubMed     Text format     Abstract available


  130. TARIQ H, Eldridge E, Welch I
    An efficient approach for feature construction of high-dimensional microarray data by random projections.
    PLoS One. 2018;13:e0196385.
    PubMed     Text format     Abstract available


  131. PANDE M, Joon A, Brewster AM, Chen WV, et al
    Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
    PLoS One. 2018;13:e0196245.
    PubMed     Text format     Abstract available


  132. YANG J, Min KW, Kim DH, Son BK, et al
    High TNFRSF12A level associated with MMP-9 overexpression is linked to poor prognosis in breast cancer: Gene set enrichment analysis and validation in large-scale cohorts.
    PLoS One. 2018;13:e0202113.
    PubMed     Text format     Abstract available


  133. CARIOU A, Rouzier R, Baffert S, Soilly AL, et al
    Multidimensional impact of breast cancer screening: Results of the multicenter prospective optisoins01 study.
    PLoS One. 2018;13:e0202385.
    PubMed     Text format     Abstract available


  134. RANASINGHE SL, Boyle GM, Fischer K, Potriquet J, et al
    Kunitz type protease inhibitor EgKI-1 from the canine tapeworm Echinococcus granulosus as a promising therapeutic against breast cancer.
    PLoS One. 2018;13:e0200433.
    PubMed     Text format     Abstract available


  135. COBO-CUENCA AI, Martin-Espinosa NM, Sampietro-Crespo A, Rodriguez-Borrego MA, et al
    Sexual dysfunction in Spanish women with breast cancer.
    PLoS One. 2018;13:e0203151.
    PubMed     Text format     Abstract available


  136. SMITH A, Mullooly M, Murphy L, Barron TI, et al
    Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
    PLoS One. 2018;13:e0202291.
    PubMed     Text format     Abstract available


  137. KOUSSEMOU M, Lorenz K, Klotz KN
    The A2B adenosine receptor in MDA-MB-231 breast cancer cells diminishes ERK1/2 phosphorylation by activation of MAPK-phosphatase-1.
    PLoS One. 2018;13:e0202914.
    PubMed     Text format     Abstract available


  138. BLACKBURN NE, Mc Veigh JG, Mc Caughan EM, Kennedy RD, et al
    The musculoskeletal consequences of latissmus dorsi breast reconstruction in women following mastectomy for breast cancer.
    PLoS One. 2018;13:e0202859.
    PubMed     Text format     Abstract available


  139. SCIOLI MG, Artuso S, D'Angelo C, Porru M, et al
    Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.
    PLoS One. 2018;13:e0203426.
    PubMed     Text format     Abstract available


  140. TAMAYO LI, Vidaurre T, Navarro Vasquez J, Casavilca S, et al
    Breast cancer subtype and survival among Indigenous American women in Peru.
    PLoS One. 2018;13:e0201287.
    PubMed     Text format     Abstract available


  141. XU S, Thompson W, Kerr J, Godbole S, et al
    Modeling interrelationships between health behaviors in overweight breast cancer survivors: Applying Bayesian networks.
    PLoS One. 2018;13:e0202923.
    PubMed     Text format     Abstract available


  142. MON AM, MacKinnon AC Jr, Traktman P
    Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.
    PLoS One. 2018;13:e0203397.
    PubMed     Text format     Abstract available


  143. GONG IY, Fox NS, Huang V, Boutros PC, et al
    Prediction of early breast cancer patient survival using ensembles of hypoxia signatures.
    PLoS One. 2018;13:e0204123.
    PubMed     Text format     Abstract available


  144. TAN MM, Ho WK, Yoon SY, Mariapun S, et al
    A case-control study of breast cancer risk factors in 7,663 women in Malaysia.
    PLoS One. 2018;13:e0203469.
    PubMed     Text format     Abstract available


  145. LI G, Guo X, Chen M, Tang L, et al
    Prevalence and spectrum of AKT1, PIK3CA, PTEN and TP53 somatic mutations in Chinese breast cancer patients.
    PLoS One. 2018;13:e0203495.
    PubMed     Text format     Abstract available


  146. YOO J, Kim BS, Chung J, Yoon HJ, et al
    Clinical value of delayed 18F-FDG PET/CT for predicting nipple-areolar complex involvement in breast cancer: A comparison with clinical symptoms and breast MRI.
    PLoS One. 2018;13:e0203649.
    PubMed     Text format     Abstract available


  147. LI J, Chen X, Qi M, Li Y, et al
    Sentinel lymph node biopsy mapped with methylene blue dye alone in patients with breast cancer: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0204364.
    PubMed     Text format     Abstract available


  148. CHANCHAN G, Xiangyu S, Fangfang S, Yan C, et al
    The efficacy and safety of targeted therapy plus fulvestrant in postmenopausal women with hormone-receptor positive advanced breast cancer: A meta-analysis of randomized-control trials.
    PLoS One. 2018;13:e0204202.
    PubMed     Text format     Abstract available


  149. CALAHORRA J, Martinez-Lara E, De Dios C, Siles E, et al
    Hypoxia modulates the antioxidant effect of hydroxytyrosol in MCF-7 breast cancer cells.
    PLoS One. 2018;13:e0203892.
    PubMed     Text format     Abstract available


  150. DING LY, Chu M, Jiao YS, Hao Q, et al
    TFDP3 regulates the apoptosis and autophagy in breast cancer cell line MDA-MB-231.
    PLoS One. 2018;13:e0203833.
    PubMed     Text format     Abstract available


  151. LIN PH, Yang HJ, Hsieh WC, Lin C, et al
    Albumin and hemoglobin adducts of estrogen quinone as biomarkers for early detection of breast cancer.
    PLoS One. 2018;13:e0201241.
    PubMed     Text format     Abstract available


  152. FOUAD TM, Ueno NT, Yu RK, Ensor JE, et al
    Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center.
    PLoS One. 2018;13:e0204372.
    PubMed     Text format     Abstract available


  153. KAZEMI NOUREINI S, Fatemi L, Wink M
    Telomere shortening in breast cancer cells (MCF7) under treatment with low doses of the benzylisoquinoline alkaloid chelidonine.
    PLoS One. 2018;13:e0204901.
    PubMed     Text format     Abstract available



  154. Retraction: Mitochondrial Dysfunction Promotes Breast Cancer Cell Migration and Invasion through HIF1alpha Accumulation via Increased Production of Reactive Oxygen Species.
    PLoS One. 2018;13:e0205288.
    PubMed     Text format    


  155. GOKMEN-POLAR Y, True JD, Vieth E, Gu Y, et al
    Quantitative phosphoproteomic analysis identifies novel functional pathways of tumor suppressor DLC1 in estrogen receptor positive breast cancer.
    PLoS One. 2018;13:e0204658.
    PubMed     Text format     Abstract available


  156. COLLIGNON O, Han J, An H, Oh S, et al
    Comparison of the modified unbounded penalty and the LASSO to select predictive genes of response to chemotherapy in breast cancer.
    PLoS One. 2018;13:e0204897.
    PubMed     Text format     Abstract available


  157. ANSARIPOUR A, Zendehdel K, Tadayon N, Sadeghi F, et al
    Use of data-mining to support real-world cost analyses: An example using HER2-positive breast cancer in Iran.
    PLoS One. 2018;13:e0205079.
    PubMed     Text format     Abstract available


  158. ZUGNI F, Ruju F, Pricolo P, Alessi S, et al
    The added value of whole-body magnetic resonance imaging in the management of patients with advanced breast cancer.
    PLoS One. 2018;13:e0205251.
    PubMed     Text format     Abstract available


  159. HARANO K, Wang Y, Lim B, Seitz RS, et al
    Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype.
    PLoS One. 2018;13:e0204513.
    PubMed     Text format     Abstract available


  160. VAN TREUREN T, Vishwanatha JK
    CRISPR deletion of MIEN1 in breast cancer cells.
    PLoS One. 2018;13:e0204976.
    PubMed     Text format     Abstract available


  161. HARALDSDOTTIR A, Torfadottir JE, Valdimarsdottir UA, Adami HO, et al
    Correction: Dietary habits in adolescence and midlife and risk of breast cancer in older women.
    PLoS One. 2018;13:e0206026.
    PubMed     Text format     Abstract available


  162. ALOTAIBI RM, Rezk HR, Juliana CI, Guure C, et al
    Breast cancer mortality in Saudi Arabia: Modelling observed and unobserved factors.
    PLoS One. 2018;13:e0206148.
    PubMed     Text format     Abstract available


  163. DUMANE VA, Bakst R, Green S
    Dose to organs in the supraclavicular region when covering the Internal Mammary Nodes (IMNs) in breast cancer patients: A comparison of Volumetric Modulated Arc Therapy (VMAT) versus 3D and VMAT.
    PLoS One. 2018;13:e0205770.
    PubMed     Text format     Abstract available


  164. COVARRUBIAS G, Cha A, Rahmy A, Lorkowski M, et al
    Imaging breast cancer using a dual-ligand nanochain particle.
    PLoS One. 2018;13:e0204296.
    PubMed     Text format     Abstract available


  165. SEMLALI A, Almutairi M, Rouabhia M, Reddy Parine N, et al
    Novel sequence variants in the TLR6 gene associated with advanced breast cancer risk in the Saudi Arabian population.
    PLoS One. 2018;13:e0203376.
    PubMed     Text format     Abstract available


  166. ROCHA-BRISCHILIARI SC, Andrade L, Nihei OK, Brischiliari A, et al
    Spatial distribution of breast cancer mortality: Socioeconomic disparities and access to treatment in the state of Parana, Brazil.
    PLoS One. 2018;13:e0205253.
    PubMed     Text format     Abstract available


  167. VENUGOPAL V, Krishnan S, Palanimuthu VR, Sankarankutty S, et al
    Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities.
    PLoS One. 2018;13:e0206109.
    PubMed     Text format     Abstract available


  168. BEZERRA IC, da Silva RM, Oliveira CP, Brasil CCP, et al
    Mastectomized women's perception of breast cancer early detection.
    PLoS One. 2018;13:e0206405.
    PubMed     Text format     Abstract available


  169. SALAGAME U, Banks E, O'Connell DL, Egger S, et al
    Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.
    PLoS One. 2018;13:e0205034.
    PubMed     Text format     Abstract available


  170. CUELLO-LOPEZ J, Fidalgo-Zapata A, Lopez-Agudelo L, Vasquez-Trespalacios E, et al
    Platelet-to-lymphocyte ratio as a predictive factor of complete pathologic response to neoadjuvant chemotherapy in breast cancer.
    PLoS One. 2018;13:e0207224.
    PubMed     Text format     Abstract available



  171. Correction: Manganese-porphyrin-enhanced MRI for the detection of cancer cells: A quantitative in vitro investigation with multiple clinical subtypes of breast cancer.
    PLoS One. 2018;13:e0206720.
    PubMed     Text format     Abstract available


  172. CAMPOS-RODRIGUEZ F, Cruz-Medina A, Selma MJ, Rodriguez-de-la-Borbolla-Artacho M, et al
    Association between sleep-disordered breathing and breast cancer aggressiveness.
    PLoS One. 2018;13:e0207591.
    PubMed     Text format     Abstract available


  173. KWON MJ, Lee SB, Han J, Lee JE, et al
    BCT score predicts chemotherapy benefit in Asian patients with hormone receptor-positive, HER2-negative, lymph node-negative breast cancer.
    PLoS One. 2018;13:e0207155.
    PubMed     Text format     Abstract available


  174. ALSHAREEDA AT, Rakha E, Alghwainem A, Alrfaei B, et al
    The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks.
    PLoS One. 2018;13:e0207593.
    PubMed     Text format     Abstract available


  175. MBOGE MY, Chen Z, Wolff A, Mathias JV, et al
    Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
    PLoS One. 2018;13:e0207417.
    PubMed     Text format     Abstract available


  176. GROSSE FRIE K, Kamate B, Traore CB, Ly M, et al
    Factors associated with time to first healthcare visit, diagnosis and treatment, and their impact on survival among breast cancer patients in Mali.
    PLoS One. 2018;13:e0207928.
    PubMed     Text format     Abstract available


  177. GOKAL K, Munir F, Ahmed S, Kancherla K, et al
    Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial.
    PLoS One. 2018;13:e0206874.
    PubMed     Text format     Abstract available


  178. SUN L, Legood R, Dos-Santos-Silva I, Gaiha SM, et al
    Global treatment costs of breast cancer by stage: A systematic review.
    PLoS One. 2018;13:e0207993.
    PubMed     Text format     Abstract available


  179. DAVIS M, Tripathi S, Hughley R, He Q, et al
    AR negative triple negative or "quadruple negative" breast cancers in African American women have an enriched basal and immune signature.
    PLoS One. 2018;13:e0196909.
    PubMed     Text format     Abstract available


  180. BALOGH KN, Templeton DJ, Cross JV
    Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.
    PLoS One. 2018;13:e0197702.
    PubMed     Text format     Abstract available


  181. KOUTRAS A, Lazaridis G, Koliou GA, Kouvatseas G, et al
    Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.
    PLoS One. 2018;13:e0207707.
    PubMed     Text format     Abstract available


  182. BOU-DARGHAM MJ, Liu Y, Sang QA, Zhang J, et al
    Subgrouping breast cancer patients based on immune evasion mechanisms unravels a high involvement of transforming growth factor-beta and decoy receptor 3.
    PLoS One. 2018;13:e0207799.
    PubMed     Text format     Abstract available


    January 2017
  183. SU S, Bao H, Wang X, Wang Z, et al
    The quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study.
    PLoS One. 2017;12:e0184866.
    PubMed     Text format     Abstract available


  184. ZEIDAN AM, Long JB, Wang R, Hu X, et al
    Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.
    PLoS One. 2017;12:e0184747.
    PubMed     Text format     Abstract available


  185. LEFTIN A, Ben-Chetrit N, Klemm F, Joyce JA, et al
    Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer.
    PLoS One. 2017;12:e0184765.
    PubMed     Text format     Abstract available


  186. FUKADA I, Ito Y, Kobayashi K, Shibayama T, et al
    The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.
    PLoS One. 2017;12:e0184322.
    PubMed     Text format     Abstract available


  187. LU S, Qian Y, Huang X, Yu H, et al
    The association of dietary pattern and breast cancer in Jiangsu, China: A population-based case-control study.
    PLoS One. 2017;12:e0184453.
    PubMed     Text format     Abstract available


  188. POPOLIN CP, Reis JPB, Becceneri AB, Graminha AE, et al
    Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    PLoS One. 2017;12:e0183275.
    PubMed     Text format     Abstract available


  189. GOTZ TI, Lahmer G, Strnad V, Bert C, et al
    A tool to automatically analyze electromagnetic tracking data from high dose rate brachytherapy of breast cancer patients.
    PLoS One. 2017;12:e0183608.
    PubMed     Text format     Abstract available


  190. PARK NJ, Chang Y, Bender C, Conley Y, et al
    Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.
    PLoS One. 2017;12:e0184174.
    PubMed     Text format     Abstract available


  191. BUONOMO OC, Caredda E, Portarena I, Vanni G, et al
    New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
    PLoS One. 2017;12:e0184680.
    PubMed     Text format     Abstract available


  192. PADALA C, Tupurani MA, Puranam K, Gantala S, et al
    Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
    PLoS One. 2017;12:e0184448.
    PubMed     Text format     Abstract available


  193. FUJII T, Reuben JM, Huo L, Espinosa Fernandez JR, et al
    Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
    PLoS One. 2017;12:e0185231.
    PubMed     Text format     Abstract available


  194. LAMPA M, Arlt H, He T, Ospina B, et al
    Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    PLoS One. 2017;12:e0185092.
    PubMed     Text format     Abstract available


  195. SCHMITZ AMT, Veldhuis WB, Menke-Pluijmers MBE, van der Kemp WJM, et al
    Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRI.
    PLoS One. 2017;12:e0183855.
    PubMed     Text format     Abstract available


  196. GSCHWANTLER-KAULICH D, Weingartshofer S, Grunt TW, Mairhofer M, et al
    Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.
    PLoS One. 2017;12:e0185566.
    PubMed     Text format     Abstract available


  197. SUCHANSKI J, Tejchman A, Zacharski M, Piotrowska A, et al
    Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
    PLoS One. 2017;12:e0184970.
    PubMed     Text format     Abstract available


  198. ZHANG W, Wang W, Chai W, Luo X, et al
    Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study.
    PLoS One. 2017;12:e0181555.
    PubMed     Text format     Abstract available


  199. DI NAPOLI A, Pepe G, Giarnieri E, Cippitelli C, et al
    Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
    PLoS One. 2017;12:e0181097.
    PubMed     Text format     Abstract available


  200. SANO H, Goto R, Hamashima C
    Does lack of resources impair access to breast and cervical cancer screening in Japan?
    PLoS One. 2017;12:e0180819.
    PubMed     Text format     Abstract available


  201. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Text format     Abstract available


  202. MARQUEZ-RODAS I, Pollan M, Escudero MJ, Ruiz A, et al
    Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Alamo III" retrospective study.
    PLoS One. 2017;12:e0184181.
    PubMed     Text format     Abstract available


  203. CILEK EE, Ozturk H, Gur Dedeoglu B
    Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines.
    PLoS One. 2017;12:e0185558.
    PubMed     Text format     Abstract available


  204. AUKES K, Forsman C, Brady NJ, Astleford K, et al
    Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions.
    PLoS One. 2017;12:e0185736.
    PubMed     Text format     Abstract available


  205. KORKOLA JE, Collisson EA, Heiser LM, Oates C, et al
    Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
    PLoS One. 2017;12:e0186551.
    PubMed     Text format     Abstract available


  206. QIAO W, Jia Z, Liu H, Liu Q, et al
    Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0186191.
    PubMed     Text format     Abstract available


  207. XIE F, Hosany S, Zhong S, Jiang Y, et al
    MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
    PLoS One. 2017;12:e0185565.
    PubMed     Text format     Abstract available


  208. THIRUNAVUKKARASAN M, Wang C, Rao A, Hind T, et al
    Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells.
    PLoS One. 2017;12:e0186334.
    PubMed     Text format     Abstract available


  209. MAHAJAN AS, Sugita BM, Duttargi AN, Saenz F, et al
    Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.
    PLoS One. 2017;12:e0186190.
    PubMed     Text format     Abstract available


  210. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    PubMed     Text format     Abstract available


  211. HEQUET D, Callens C, Gentien D, Albaud B, et al
    Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna(R) Test in the management of early-stage breast cancers.
    PLoS One. 2017;12:e0185753.
    PubMed     Text format     Abstract available


  212. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    PubMed     Text format     Abstract available


  213. VALIANATOS G, Valcikova B, Growkova K, Verlande A, et al
    A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PLoS One. 2017;12:e0185801.
    PubMed     Text format     Abstract available


  214. HEBBRECHT T, Van Audenhove I, Zwaenepoel O, Verhelle A, et al
    VCA nanobodies target N-WASp to reduce invadopodium formation and functioning.
    PLoS One. 2017;12:e0185076.
    PubMed     Text format     Abstract available


  215. NISHIMUKAI A, Inoue N, Kira A, Takeda M, et al
    Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
    PLoS One. 2017;12:e0184508.
    PubMed     Text format     Abstract available


  216. SERRANO-GOMEZ SJ, Sanabria-Salas MC, Garay J, Baddoo MC, et al
    Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.
    PLoS One. 2017;12:e0183179.
    PubMed     Text format     Abstract available


  217. DIMITROPOULOS K, Barmpoutis P, Zioga C, Kamas A, et al
    Grading of invasive breast carcinoma through Grassmannian VLAD encoding.
    PLoS One. 2017;12:e0185110.
    PubMed     Text format     Abstract available


  218. KANG HJ, Kim SW, Son SH
    The feasibility of a heart block with an electron compensation as an alternative whole breast radiotherapy technique in patients with underlying cardiac or pulmonary disease.
    PLoS One. 2017;12:e0184137.
    PubMed     Text format     Abstract available


  219. CHEN Z, Yang J, Li S, Lv M, et al
    Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
    PLoS One. 2017;12:e0182397.
    PubMed     Text format     Abstract available


  220. PARK JM, Bae SJ, Yoon C, Lee HS, et al
    Comparison of patients with small (</=2 cm) breast cancer according to adherence to breast screening program.
    PLoS One. 2017;12:e0186988.
    PubMed     Text format     Abstract available


  221. LAI HW, Liu LC, Ouyang F, Yao CC, et al
    Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent(R) eBx(R) System for the management of early stage breast cancer in Taiwan.
    PLoS One. 2017;12:e0185876.
    PubMed     Text format     Abstract available


  222. HENLE AM, Nassar A, Puglisi-Knutson D, Youssef B, et al
    Downregulation of TAP1 and TAP2 in early stage breast cancer.
    PLoS One. 2017;12:e0187323.
    PubMed     Text format     Abstract available


  223. COIGNET MV, Zirpoli GR, Roberts MR, Khoury T, et al
    Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study.
    PLoS One. 2017;12:e0187205.
    PubMed     Text format     Abstract available


  224. JOHANNESSEN C, Moi L, Kiselev Y, Pedersen MI, et al
    Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
    PLoS One. 2017;12:e0186658.
    PubMed     Text format     Abstract available


  225. REESE DE, Henderson MC, Silver M, Mulpuri R, et al
    Breast density does not impact the ability of Videssa(R) Breast to detect breast cancer in women under age 50.
    PLoS One. 2017;12:e0186198.
    PubMed     Text format     Abstract available


  226. SUNG PL, Wen KC, Chen YJ, Chao TC, et al
    The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
    PLoS One. 2017;12:e0185615.
    PubMed     Text format     Abstract available


  227. LAROCHE F, Perrot S, Medkour T, Cottu PH, et al
    Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.
    PLoS One. 2017;12:e0187165.
    PubMed     Text format     Abstract available


  228. WAKAI R, Ishitsuka M, Kishimoto T, Ochiai T, et al
    Identification of genes and critical control proteins associated with inflammatory breast cancer using network controllability.
    PLoS One. 2017;12:e0186353.
    PubMed     Text format     Abstract available


  229. THERIAU CF, Sauve OS, Beaudoin MS, Wright DC, et al
    Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation.
    PLoS One. 2017;12:e0183897.
    PubMed     Text format     Abstract available


  230. HIRONAKA-MITSUHASHI A, Matsuzaki J, Takahashi RU, Yoshida M, et al
    A tissue microRNA signature that predicts the prognosis of breast cancer in young women.
    PLoS One. 2017;12:e0187638.
    PubMed     Text format     Abstract available


  231. SYED S, Schober J, Blanco A, Zustiak SP, et al
    Morphological adaptations in breast cancer cells as a function of prolonged passaging on compliant substrates.
    PLoS One. 2017;12:e0187853.
    PubMed     Text format     Abstract available


  232. CARLSEN JF, Ewertsen C, Sletting S, Talman ML, et al
    Strain histograms are equal to strain ratios in predicting malignancy in breast tumours.
    PLoS One. 2017;12:e0186230.
    PubMed     Text format     Abstract available


  233. KYEONG S, Cha YJ, Ahn SG, Suh SH, et al
    Subtypes of breast cancer show different spatial distributions of brain metastases.
    PLoS One. 2017;12:e0188542.
    PubMed     Text format     Abstract available


  234. THOMPSON KJ, Ingle JN, Tang X, Chia N, et al
    A comprehensive analysis of breast cancer microbiota and host gene expression.
    PLoS One. 2017;12:e0188873.
    PubMed     Text format     Abstract available


  235. MARINHO EDC, Custodio IDD, Ferreira IB, Crispim CA, et al
    Impact of chemotherapy on perceptions related to food intake in women with breast cancer: A prospective study.
    PLoS One. 2017;12:e0187573.
    PubMed     Text format     Abstract available


  236. AZIZI M, Ghourchian H, Yazdian F, Dashtestani F, et al
    Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231.
    PLoS One. 2017;12:e0188639.
    PubMed     Text format     Abstract available


  237. MAYORAL-VARO V, Calcabrini A, Sanchez-Bailon MP, Martin-Perez J, et al
    miR205 inhibits stem cell renewal in SUM159PT breast cancer cells.
    PLoS One. 2017;12:e0188637.
    PubMed     Text format     Abstract available


  238. ARENAS M, Garcia-Heredia A, Cabre N, Luciano-Mateo F, et al
    Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients.
    PLoS One. 2017;12:e0188633.
    PubMed     Text format     Abstract available


  239. AHN SG, Bae SJ, Yoon C, Cha YJ, et al
    Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.
    PLoS One. 2017;12:e0187679.
    PubMed     Text format     Abstract available


  240. ZEUNE L, van Dalum G, Decraene C, Proudhon C, et al
    Quantifying HER-2 expression on circulating tumor cells by ACCEPT.
    PLoS One. 2017;12:e0186562.
    PubMed     Text format     Abstract available


  241. TAKEUCHI H, Abe M, Takumi Y, Hashimoto T, et al
    The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer.
    PLoS One. 2017;12:e0189166.
    PubMed     Text format     Abstract available


  242. KASANGIAN AA, Gherardi G, Biagioli E, Torri V, et al
    The prognostic role of tumor size in early breast cancer in the era of molecular biology.
    PLoS One. 2017;12:e0189127.
    PubMed     Text format     Abstract available


  243. AGARWAL S, Ying J, Boucher KM, Agarwal JP, et al
    The association between socioeconomic factors and breast cancer-specific survival varies by race.
    PLoS One. 2017;12:e0187018.
    PubMed     Text format     Abstract available


  244. DAVIES G, Lobanova L, Dawicki W, Groot G, et al
    Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.
    PLoS One. 2017;12:e0187191.
    PubMed     Text format     Abstract available


  245. ZHANG H, Diao H, Jia L, Yuan Y, et al
    Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
    PLoS One. 2017;12:e0188960.
    PubMed     Text format     Abstract available


  246. ALEMAR B, Gregorio C, Herzog J, Matzenbacher Bittar C, et al
    BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
    PLoS One. 2017;12:e0187630.
    PubMed     Text format     Abstract available


  247. KIM GE, Lee JS, Park MH, Yoon JH, et al
    Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
    PLoS One. 2017;12:e0187635.
    PubMed     Text format     Abstract available


  248. HENDERSON HJ, Karanam B, Samant R, Vig K, et al
    Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.
    PLoS One. 2017;12:e0189662.
    PubMed     Text format     Abstract available


  249. ZEINOMAR N, Thai A, Cloud AJ, McDonald JA, et al
    Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry.
    PLoS One. 2017;12:e0189118.
    PubMed     Text format     Abstract available


  250. SYED BM, Morgan D, Setty T, Green AR, et al
    Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2017;12:e0188528.
    PubMed     Text format     Abstract available


  251. FATIMA I, El-Ayachi I, Taotao L, Lillo MA, et al
    The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    PLoS One. 2017;12:e0189864.
    PubMed     Text format     Abstract available


  252. SOBRAL-LEITE M, Lips EH, Vieira-Monteiro HA, Giacomin LC, et al
    Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.
    PLoS One. 2017;12:e0189750.
    PubMed     Text format     Abstract available


  253. DABI Y, Darrigues L, Pons K, Mabille M, et al
    Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms.
    PLoS One. 2017;12:e0189385.
    PubMed     Text format     Abstract available


  254. LIU CY, Lau KY, Hsu CC, Chen JL, et al
    Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
    PLoS One. 2017;12:e0189007.
    PubMed     Text format     Abstract available


  255. RUMNEY RMH, Coffelt SB, Neale TA, Dhayade S, et al
    PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development.
    PLoS One. 2017;12:e0188591.
    PubMed     Text format     Abstract available


  256. FIOCCHETTI M, Cipolletti M, Marino M
    Compensatory role of Neuroglobin in nervous and non-nervous cancer cells in response to the nutrient deprivation.
    PLoS One. 2017;12:e0189179.
    PubMed     Text format     Abstract available


  257. CATTANEO ER, Prieto ED, Garcia-Fabiani MB, Montanaro MA, et al
    Glycerol-3-phosphate acyltransferase 2 expression modulates cell roughness and membrane permeability: An atomic force microscopy study.
    PLoS One. 2017;12:e0189031.
    PubMed     Text format     Abstract available


  258. CARNESECCHI J, Cerutti C, Vanacker JM, Forcet C, et al
    ERRalpha protein is stabilized by LSD1 in a demethylation-independent manner.
    PLoS One. 2017;12:e0188871.
    PubMed     Text format     Abstract available


  259. BENNANI-BAITI B, Dietzel M, Baltzer PA
    MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    PLoS One. 2017;12:e0188679.
    PubMed     Text format     Abstract available


  260. DENIZ S, Kurt B, Oguzoncul AF, Nazlican E, et al
    Knowledge, attitudes and behaviours of women regarding breast and cervical cancer in Malatya, Turkey.
    PLoS One. 2017;12:e0188571.
    PubMed     Text format     Abstract available


  261. ORTIZ AB, Garcia D, Vicente Y, Palka M, et al
    Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    PLoS One. 2017;12:e0188068.
    PubMed     Text format     Abstract available


  262. JIN D, Lee H
    FGMD: A novel approach for functional gene module detection in cancer.
    PLoS One. 2017;12:e0188900.
    PubMed     Text format     Abstract available


  263. PAUL B, Royston KJ, Li Y, Stoll ML, et al
    Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition.
    PLoS One. 2017;12:e0189756.
    PubMed     Text format     Abstract available


  264. HANLEY JA, Hannigan A, O'Brien KM
    Mortality reductions due to mammography screening: Contemporary population-based data.
    PLoS One. 2017;12:e0188947.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: